We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$6.86B
AUM Growth
-$3.41B
Cap. Flow
-$3.78B
Cap. Flow %
-55.19%
Top 10 Hldgs %
25.96%
Holding
2,871
New
973
Increased
552
Reduced
524
Closed
811

Top Buys

Rank Stock Value
1
IWD icon
iShares Russell 1000 Value ETF
IWD
+$48M
2
AEP icon
American Electric Power
AEP
+$40.9M
3
CMCSA icon
Comcast
CMCSA
+$38.2M
4
ETR icon
Entergy
ETR
+$30.6M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$27.9M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$378M
2
AMZN icon
Amazon
AMZN
+$336M
3
AAPL icon
Apple
AAPL
+$294M
4
BABA icon
Alibaba
BABA
+$258M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$136M

Sector Composition

Rank Sector Weight
1 Technology 12.92%
2 Consumer Discretionary 8.02%
3 Utilities 7.46%
4 Healthcare 7.42%
5 Financials 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRTA icon
2501
Prothena Corp
PRTA
$485M
– –
-15,692
Closed -$188K
PSEC icon
2502
Prospect Capital
PSEC
$1.17B
– –
-42,368
Closed -$229K
PSMT icon
2503
Pricesmart
PSMT
$5.33B
– –
-3,690
Closed -$336K
PSNL icon
2504
Personalis
PSNL
$1.96B
– –
-97,340
Closed -$3.56M
PTEN icon
2505
Patterson-UTI
PTEN
$4.71B
– –
-265,679
Closed -$1.4M
PTGX icon
2506
Protagonist Therapeutics
PTGX
$9.99B
– –
-15,701
Closed -$317K
PZZA icon
2507
Papa John's
PZZA
$788M
– –
-6,057
Closed -$514K
HTT
2508
High Templar Tech Ltd
HTT
$388M
– –
-181,600
Closed -$251K
QGEN icon
2509
Qiagen
QGEN
$9.1B
– –
-84,147
Closed -$4.72M
QNCX icon
2510
CALL
Quince Therapeutics
QNCX
$34.5M
– –
-113
Closed -$633K
QNCX icon
2511
Quince Therapeutics
QNCX
$34.5M
– –
-58
Closed -$321K
QRVO icon
2512
Qorvo
QRVO
$8.43B
– –
-11,030
Closed -$1.83M
QTRX icon
2513
Quanterix
QTRX
$141M
– –
-44,913
Closed -$2.09M
RBC icon
2514
RBC Bearings
RBC
$16B
– –
-4,844
Closed -$867K
RCKT icon
2515
Rocket Pharmaceuticals
RCKT
$385M
– –
-36,085
Closed -$1.98M
RCUS icon
2516
Arcus Biosciences
RCUS
$3.86B
– –
-8,390
Closed -$218K
REAL icon
2517
The RealReal
REAL
$1.35B
– –
-38,448
Closed -$751K
REG icon
2518
Regency Centers
REG
$13.9B
– –
-32,941
Closed -$1.5M
RELX icon
2519
RELX
RELX
$62.6B
– –
-8,555
Closed -$211K
REPL icon
2520
Replimune Group
REPL
$1.39B
– –
-43,250
Closed -$1.65M
REVG
2521
DELISTED
REV Group
REVG
– –
-25,902
Closed -$228K
REXR icon
2522
Rexford Industrial Realty
REXR
$8.3B
– –
-21,000
Closed -$1.03M
RGLD icon
2523
Royal Gold
RGLD
$21.9B
– –
-26,069
Closed -$2.77M
RGS icon
2524
Regis Corp
RGS
$66.9M
– –
-1,990
Closed -$366K
RIOT icon
2525
Riot Platforms
RIOT
$7.44B
– –
-14,090
Closed -$239K
99 100
101
102 103

Similar funds

FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Michael Gelband's Q1 2021 Portfolio in Review

As of Q1 2021, Michael Gelband held 2,871 positions worth $6.86B, down 33% from $10.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Michael Gelband withdrew a net $3.78B in Q1 2021, closing 811 positions and reducing 524 holdings. Its most notable exit was Alibaba, an estimated $258M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Utilities.

Against the trend, Michael Gelband opened a new position in Comcast worth $39.1M.

  • Michael Gelband's largest Q1 2021 buy was Comcast: 722,523 shares worth $39.1M.
  • Michael Gelband added most to iShares Russell 1000 Value ETF in Q1 2021, an estimated $48M increase.
  • Michael Gelband's biggest Q1 2021 reduction was Microsoft, cutting an estimated $378M.
  • Michael Gelband fully exited Alibaba in Q1 2021, selling an estimated $258M.
  • Michael Gelband's ten largest holdings make up 26% of its $6.86B portfolio in Q1 2021.
  • Michael Gelband opened 973 new positions and closed 811 in Q1 2021.
  • Michael Gelband's portfolio value fell 33% quarter-over-quarter to $6.86B.

Based on ExodusPoint Capital Management's 13F filing for Q1 2021, filed 17 May 2021.